Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Dimethyl fumarate for treating relapsing multiple sclerosis.

Sheremata W, Brown AD, Rammohan KW.

Expert Opin Drug Saf. 2014 Nov 8:1-10. [Epub ahead of print]

PMID:
25382392
[PubMed - as supplied by publisher]
2.

Increased Seroreactivity to Human T Cell Lymphoma/Leukemia Virus-Related Endogenous Sequence-1 Gag Peptides in Patients with Human T Cell Lymphoma/Leukemia Virus Myelopathy.

Perzova R, Graziano E, Sanghi S, Welch C, Benz P, Abbott L, Lalone D, Glaser J, Loughran T, Sheremata W, Poiesz BJ.

AIDS Res Hum Retroviruses. 2014 Nov 19. [Epub ahead of print]

PMID:
25295378
[PubMed - as supplied by publisher]
3.

Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathy.

Perzova R, Graziano E, Sanghi S, Welch C, Benz P, Abbott L, Lalone D, Glaser J, Loughran T, Sheremata W, Poiesz BJ.

Virol J. 2013 Dec 23;10:360. doi: 10.1186/1743-422X-10-360.

PMID:
24365054
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Randomized study combining interferon and glatiramer acetate in multiple sclerosis.

Lublin FD, Cofield SS, Cutter GR, Conwit R, Narayana PA, Nelson F, Salter AR, Gustafson T, Wolinsky JS; CombiRx Investigators.

Ann Neurol. 2013 Mar;73(3):327-40. doi: 10.1002/ana.23863. Epub 2013 Mar 11.

PMID:
23424159
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Multiple sclerosis and the spinal cord.

Sheremata W, Tornes L.

Neurol Clin. 2013 Feb;31(1):55-77. doi: 10.1016/j.ncl.2012.09.007. Review.

PMID:
23186896
[PubMed - indexed for MEDLINE]
6.

Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.

Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT, Viglietta V, Dawson KT; CONFIRM Study Investigators.

N Engl J Med. 2012 Sep 20;367(12):1087-97. Erratum in: N Engl J Med. 2012 Oct 25;367(17):1673.

PMID:
22992072
[PubMed - indexed for MEDLINE]
Free Article
7.

Association between paroxysmal tonic spasms and neuromyelitis optica.

Usmani N, Bedi G, Lam BL, Sheremata WA.

Arch Neurol. 2012 Jan;69(1):121-4. doi: 10.1001/archneurol.2011.832.

PMID:
22232353
[PubMed - indexed for MEDLINE]
8.

Impact of rituximab on relapse rate and disability in neuromyelitis optica.

Bedi GS, Brown AD, Delgado SR, Usmani N, Lam BL, Sheremata WA.

Mult Scler. 2011 Oct;17(10):1225-30. doi: 10.1177/1352458511404586. Epub 2011 May 26.

PMID:
21622594
[PubMed - indexed for MEDLINE]
9.

Human T-lymphotropic virus type I or II (HTLV-I/II) associated with recurrent longitudinally extensive transverse myelitis (LETM): two case reports.

Delgado SR, Sheremata WA, Brown AD, McCarthy M.

J Neurovirol. 2010 May;16(3):249-53. doi: 10.3109/13550281003801493.

PMID:
20450377
[PubMed - indexed for MEDLINE]
10.

Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis.

Radue EW, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Rudick RA, Lublin FD, Weinstock-Guttman B, Wynn DR, Fisher E, Papadopoulou A, Lynn F, Panzara MA, Sandrock AW; SENTINEL Investigators.

J Neurol Sci. 2010 May 15;292(1-2):28-35. doi: 10.1016/j.jns.2010.02.012. Epub 2010 Mar 16.

PMID:
20236661
[PubMed - indexed for MEDLINE]
11.

LGL leukemia and HTLV.

Thomas A, Perzova R, Abbott L, Benz P, Poiesz MJ, Dube S, Loughran T, Ferrer J, Sheremata W, Glaser J, Leon-Ponte M, Poiesz BJ.

AIDS Res Hum Retroviruses. 2010 Jan;26(1):33-40. doi: 10.1089/aid.2009.0124.

PMID:
20047475
[PubMed - indexed for MEDLINE]
12.

250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study.

O'Connor P, Filippi M, Arnason B, Comi G, Cook S, Goodin D, Hartung HP, Jeffery D, Kappos L, Boateng F, Filippov V, Groth M, Knappertz V, Kraus C, Sandbrink R, Pohl C, Bogumil T; BEYOND Study Group, O'Connor P, Filippi M, Arnason B, Cook S, Goodin D, Hartung HP, Kappos L, Jeffery D, Comi G.

Lancet Neurol. 2009 Oct;8(10):889-97. doi: 10.1016/S1474-4422(09)70226-1. Epub 2009 Sep 2. Erratum in: Lancet Neurol. 2012 Jan;11(1):27. Cree, B [added]; Harung, H-P [corrected to Hartung, H-P]. Lancet Neurol. 2009 Nov;8(11):981. Lancet Neurol. 2011 Feb;10(2):115.

PMID:
19729344
[PubMed - indexed for MEDLINE]
13.

Parkinsonism/dystonia syndrome secondary to multiple sclerosis with anti-basal-ganglia antibodies.

Delgado S, Baez S, Singer C, Sengun C, Sheremata WA, Papapetropoulos S.

Mov Disord. 2009 Jan 30;24(2):309-11. doi: 10.1002/mds.22331. No abstract available.

PMID:
18951536
[PubMed - indexed for MEDLINE]
14.

Evidence of platelet activation in multiple sclerosis.

Sheremata WA, Jy W, Horstman LL, Ahn YS, Alexander JS, Minagar A.

J Neuroinflammation. 2008 Jun 27;5:27. doi: 10.1186/1742-2094-5-27.

PMID:
18588683
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosis.

Sharma KR, Saadia D, Facca AG, Bhatia R, Ayyar DR, Sheremata W.

J Clin Neuromuscul Dis. 2008 Jun;9(4):385-96. doi: 10.1097/CND.0b013e31816f18e3.

PMID:
18525422
[PubMed - indexed for MEDLINE]
16.

Interferon-beta1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosis.

Sheremata WA, Jy W, Delgado S, Minagar A, McLarty J, Ahn Y.

J Neuroinflammation. 2006 Sep 4;3:23.

PMID:
16952316
[PubMed]
Free PMC Article
17.

The role of CD4+ T-cells in the development of MS.

Delgado S, Sheremata WA.

Neurol Res. 2006 Apr;28(3):245-9. Review.

PMID:
16687048
[PubMed - indexed for MEDLINE]
18.

The role of alpha-4 integrin in the aetiology of multiple sclerosis: current knowledge and therapeutic implications.

Sheremata WA, Minagar A, Alexander JS, Vollmer T.

CNS Drugs. 2005;19(11):909-22. Review.

PMID:
16268663
[PubMed - indexed for MEDLINE]
19.

Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis.

O'Connor P, Miller D, Riester K, Yang M, Panzara M, Dalton C, Miszkiel K, Khan O, Rice G, Sheremata W; International Natalizumab Trial Group.

Mult Scler. 2005 Oct;11(5):568-72.

PMID:
16193895
[PubMed - indexed for MEDLINE]
20.

Endothelial microparticles (EMP) bind and activate monocytes: elevated EMP-monocyte conjugates in multiple sclerosis.

Jy W, Minagar A, Jimenez JJ, Sheremata WA, Mauro LM, Horstman LL, Bidot C, Ahn YS.

Front Biosci. 2004 Sep 1;9:3137-44.

PMID:
15353343
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk